Accedi a banche dati online | Convegnodetail
mail
Anteprima di stampa
 
 

1st Rare and Genetic Neurodegenerative Drug Development Summit

Evvnt Promotion / evvnt
-
22.06.2022 - 23.06.2022  Online
Time: 08:50 - 16:00
 
Temi della conferenza
Advance Life-Changing Therapies for Adolescents and Adults With Rare Neurological Disorders

Welcome to the 1st Rare and Genetic Neurodegenerative Drug Development Summit! This trailblazing meeting will be discussing, debating and exploring pivotal rare and genetic neurodegenerative disease research making industry news headlines.

Pioneers in this exclusive industry are convening online, this June, to network and learn from experts in pharma, biotech and academia.
Professional congress organizer (PCO)
Hanson Wade
Annotazioni
Speakers: Anka G. Ehrhardt, Director, Cell-Based Assays / Analytical Research and Development, Merck, Christopher Missling, President and Chief, Executive Officer, Anavex Life Sciences, David Theron, Development Director in Neurology, Servier & more
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/1056250-2?pid=4832
Mr. Hanson Wade
 
Categorie
Medicina General
Lingua
Inglese
Quote del Congresso
Drug Developer Pricing - Conference Pass: USD 2099.0, Solution Provider Pricing - Conference Pass: USD 2599.0
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

Anästhesie in Entwicklungsländern e. V.Hilfswerk AustriaOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Swiss Tropical and Public Health InstituteÖsterreichische Gesellschaft für Public HealthCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioÖsterreichisches Rotes KreuzÄrzte der Welt